| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | Director | $1.91M | Jun 6, 2024 | ||
| MRKR | Marker Therapeutics, Inc. | Chief Executive Officer, Director | Oct 31, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|